These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34910845)

  • 1. A Potent Strategy of Combinational Blow Toward Enhanced Cancer Chemo-Photodynamic Therapy via Sustainable GSH Elimination.
    Yu J; Xiao H; Yang Z; Qiao C; Zhou B; Jia Q; Wang Z; Wang X; Zhang R; Yang Y; Wang Z; Li J
    Small; 2022 Mar; 18(9):e2106100. PubMed ID: 34910845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of buthionine sulfoximine on the chlorin e6-based photodynamic treatment of cancer cells.
    Lee HM; Kim DH; Lee HL; Cha B; Kang DH; Jeong YI
    Arch Pharm Res; 2019 Nov; 42(11):990-999. PubMed ID: 31482490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy.
    Yang Z; Qiao C; Jia Q; Chen Z; Wang X; Liu X; Zhang R; Pu K; Wang Z
    Theranostics; 2022; 12(14):6143-6154. PubMed ID: 36168617
    [No Abstract]   [Full Text] [Related]  

  • 4. Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination.
    Rao Z; Xia Y; Jia Q; Zhu Y; Wang L; Liu G; Liu X; Yang P; Ning P; Zhang R; Zhang X; Qiao C; Wang Z
    J Nanobiotechnology; 2023 Aug; 21(1):265. PubMed ID: 37563614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
    Yang B; Keshelava N; Anderson CP; Reynolds CP
    Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-infrared photothermal liposomal nanoantagonists for amplified cancer photodynamic therapy.
    Sun H; Feng M; Chen S; Wang R; Luo Y; Yin B; Li J; Wang X
    J Mater Chem B; 2020 Aug; 8(32):7149-7159. PubMed ID: 32617545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Ca
    Zhu J; Jiao A; Li Q; Lv X; Wang X; Song X; Li B; Zhang Y; Dong X
    Acta Biomater; 2022 Jan; 137():252-261. PubMed ID: 34653696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
    Armstrong JS; Steinauer KK; Hornung B; Irish JM; Lecane P; Birrell GW; Peehl DM; Knox SJ
    Cell Death Differ; 2002 Mar; 9(3):252-63. PubMed ID: 11859408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain.
    Jiang F; Lilge L; Belcuig M; Singh G; Grenier J; Li Y; Chopp M
    Lasers Surg Med; 1998; 23(3):161-6. PubMed ID: 9779650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Park WH
    Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of AIF and GSH-ROS-JNK-ERK-iNOS pathway.
    Chowdhury AA; Chaudhuri J; Biswas N; Manna A; Chatterjee S; Mahato SK; Chaudhuri U; Jaisankar P; Bandyopadhyay S
    PLoS One; 2013; 8(9):e73672. PubMed ID: 24040019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A ROS responsive nanomedicine with enhanced photodynamic therapy via dual mechanisms: GSH depletion and biosynthesis inhibition.
    Hu J; Wang T; Zhou L; Wei S
    J Photochem Photobiol B; 2020 Aug; 209():111955. PubMed ID: 32653858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell-activated "Sustainable ROS Generator" with homogeneous intratumoral distribution property for improved anti-tumor therapy.
    Liu J; Zhao X; Nie W; Yang Y; Wu C; Liu W; Zhang K; Zhang Z; Shi J
    Theranostics; 2021; 11(1):379-396. PubMed ID: 33391481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P; Loh SY; Kelland LR; Harrap KR
    Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death.
    Habermann KJ; Grünewald L; van Wijk S; Fulda S
    Cell Death Dis; 2017 Oct; 8(10):e3067. PubMed ID: 28981107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy.
    Niu B; Liao K; Zhou Y; Wen T; Quan G; Pan X; Wu C
    Biomaterials; 2021 Oct; 277():121110. PubMed ID: 34482088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids.
    Cuperus R; van Kuilenburg AB; Leen R; Bras J; Caron HN; Tytgat GA
    Free Radic Biol Med; 2011 Sep; 51(6):1213-20. PubMed ID: 21741474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on propyl gallate-treated HeLa cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2009 Aug; 24(2):261-8. PubMed ID: 19578799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
    You BR; Park WH
    Oncol Rep; 2012 Aug; 28(2):749-57. PubMed ID: 22684917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.